Halozyme shares dive after FDA asks for more drug data
13:59 EDT 1 Aug 2012 | Reuters
(Reuters) - Regulators have asked for additional animal test data before considering Halozyme Therapeutics Inc's application for an injected version of Baxter International Inc's treatment for immune deficiency disorders.
Original Article: Halozyme shares dive after FDA asks for more drug data
More From BioPortfolio on "Halozyme shares dive after FDA asks for more drug data"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
